Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share (ITOS).
- Disclosed ownership: 10%.
- Date of event: 13 May 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 10% ownership in ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share (ITOS) on 13 May 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 10% | 3,826,692 | 0 | 3,826,692 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 10% | 3,826,692 | 0 | 3,826,692 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 6.8% | 2,618,219 | 0 | 2,618,219 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 3.2% | 1,208,473 | 0 | 1,208,473 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |